Patents Assigned to deCODE genetics ehf. ICELAND
  • Publication number: 20020165144
    Abstract: Nucleic acids comprising the neuregulin 1 gene (NRG1) and encoding NRG1 polypeptides are disclosed. Also described are related nucleic acids encoding NRG1 polypeptides; NRG1 polypeptides; antibodies that bind to NRG1 polypeptides; methods of diagnosis of susceptibility to schizophrenia; assays for agents that alter the activity of NRG1 polypeptide or which identify NRG1 binding agents, and the agents or binding agents identified by the assays; NRG1 therapeutic agents, including the NRG1 nucleic acids, NRG1 polypeptides, or agents that alter the activity of an NRG1 polypeptides; pharmaceutical compositions comprising the NRG1 therapeutic agents; as well as methods of therapy of schizophrenia.
    Type: Application
    Filed: September 5, 2001
    Publication date: November 7, 2002
    Applicant: deCODE genetics ehf, ICELAND
    Inventors: Hreinn Stefansson, Valgerdur Steinthorsdottir, Jeffrey R. Gulcher, Mark Gurney, Thorkell Andresson
  • Publication number: 20020072066
    Abstract: A role of the human BMP2 gene in osteoporosis is disclosed. Methods for diagnosis, prediction of clinical course and treatment for osteoporosis using polymorphisms in the BMP2 gene are also disclosed.
    Type: Application
    Filed: September 13, 2001
    Publication date: June 13, 2002
    Applicant: deCODE genetics ehf. ICELAND
    Inventors: Unnur Styrkarsdottir, Vala Drofn Johannsdottir